- Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbumpAn unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy “contravenes decades of agency practice.”BioSpace · 7h ago↗ source
- Lilly, with new data, to seek FDA approval of obesity drug retatrutide<figure><div><img src="https://imgproxy.divecdn.com/x5fF_ZCHHBjPFAGFuuKXSVkAgBGYTo2hZBIz9OcQdEo/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDczMjEzLmpwZ…BioPharma Dive · 9h ago↗ source
- CLINUVEL will cut up to 20% of staff, relocate HQ to New YorkFollow along as BioSpace tracks job cuts and restructuring initiatives.BioSpace